Merck to Buy Peloton for Up to $2.2 Billion, Day Before IPO

(Bloomberg) -- Merck & Co. will acquire Peloton Therapeutics Inc. for as much as $2.2 billion in cash and additional payments, making the deal just a single day before the closely held developer of...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.